Found 4 matching trials
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
PHASE2This is a multi-center study in patients with recurrent or metastatic HPV16...
Location
Multiple Locations
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
PHASE1This is a multi-center study in patients with un-resectable Recurrent or Me...
Location
CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM)
Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer
PHASE2This phase IIa study is designed to evaluate the safety and efficacy of mul...
Location
Cliniques Universitaires Saint-Luc
An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
PHASE1This is an exploratory, open, prospective multi-centre study of VB10.16 imm...
Location
Universitätsklinikum Hamburg-Eppendorf